1. Sodium dichloroacetate (1 mM) inhibited glucose production from L-lactate in kidneycortex slices from fed, starved or alloxan-diabetic rats. In general gluconeogenesis from other substrates was not inhibited. 2. Sodium dichloroacetate inhibited glucose production from L-lactate but not from pyruvate in perfused isolated kidneys from normal or alloxan-diabetic rats. 3. Sodium dichloroacetate is an inhibitor ofthe pyruvate dehydrogenase kinase reaction and it effected conversion of pyruvate dehydrogenase into its active (dephosphorylated) form in kidney in vivo. In general, pyruvate dehydrogenase was mainly in the active form in kidneys perfused or incubated with L-lactate and the inhibitory effect of dichloroacetate on glucose production was not dependent on activation of pyruvate dehydrogenase. 4. Balance data from kidney slices showed that dichloroacetate inhibits lactate uptake, glucose and pyruvate production from lactate, but not oxidation of lactate. 5. The mechanism of this effect of dichloroacetate on glucose production from lactate has not been fully defined, but evidence suggests that it may involve a fall in tissue pyruvate concentration and inhibition of pyruvate carboxylation.
Di-isopropylammonium dichloroacetate was shown by Lorini & Ciman (1962) to cause hypoglycaemia in alloxan-diabetic rats. Subsequent investigations showed that sodium dichloroacetate increased the oxidation of glucose and pyruvate and inhibited oxidations of short-and long-chain fatty acids and of ketone bodies in rat heart and diaphragm muscles (Stacpoole & Felts, 1970 Randle, 1970; McAllister et al., 1973) .
Measurement of the changes in tissue-metabolite concentrations with dichloroacetate in perfused heart suggested that the compound may activate the pyruvate dehydrogenase complex (McAllister et al., 1973) . Pyruvate dehydrogenase exists in animal tissues in dephosphorylated (active) and phosphorylated (inactive) forms, interconvertible through the pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphate phosphatase reactions (Linn et al., 1969) . Salts of dichloroacetate are inhibitors of the pyruvate dehydrogenase kinase reaction and this action results in conversion of pyruvate dehydrogenase into its active form in vivo (Whitehouse & Randle, 1973; Whitehouse et al., 1974) . This may result in enhanced oxidation of pyruvate (and hence of lactate and alanine), diminished resynthesis of glucose via the Cori and alanine cycles and hypoglycaemia in starved or diabetic animals (McAllister et al., 1973; Whitehouse et al., 1974; Blackshear et al., 1974) .
Previous studies of the mechanism of action of sodium dichloroacetate have concentrated on its peripheral effects in accelerating the oxidation of pyruvate and of substances that give rise to pyruvate. Since oxidation of pyruvate and glucose formation from pyruvate are potentially competing pathways, we decided to investigate the effects of dichloroacetate on glucose formation from lactate and pyruvate. The inhibitory effect of dichloroacetate on gluconeogenesis from lactate in rat kidney and its mechanism of action is described here.
Experimental Materials
Chemicals. Dichloroacetic acid from BDH Chemicals, Poole, Dorset, U.K., was redistilled before use. Aqueous solutions were neutralized with NaOH for kidney experiments or use in vivo or with KOH for experiments with isolated mitochondria. Biochemical reagents and enzymes were from Boehringer Corp. (London), London W.5, U.K., or Sigma (London) Chemical Co., Kingston upon Thames, Surrey, U.K. Stock solutions of L-lactic acid were standardized by spectrophotometric assay (see under 'Methods') and stored as portions at -10°C. Bovine plasma albumin (fraction V) was defatted by the method of Chen (1967) . Albumin was recovered from perfusion media by dialysis against several changes of water at 0°C followed by freeze-drying and treatment with acid charcoal as described by Chen (1967) . Radioactive compounds were from The Radiochemical Centre, Amersham, Bucks, U.K., except for dichloro[2-3H]acetate, which was synthesized by Mr. P. Crossley from 3H20 (see Kerbey et al., 1976) .
Enzymes. Pyruvate dehydrogenase phosphate phosphatase was partially purified from pig heart (Severson et al., 1974) . Arylamine acetyltransferase (EC 2.3.1.5) was purified from acetone-dried pigeon liver powder (Tabor et al., 1953) . Pyruvate carboxylase (EC 6.4.1.1) was partially purified from rat liver mitochondria (Chappell & Hansford, 1972) by the method of Scrutton et al. (1969) taken to the end of the second (NH4)2SO4 precipitation.
Rats. Male albino Wistar rats were maintained on diet 41B (modified; Oxoid, London S.E.1, U.K.) Alloxan-diabetes was induced by tail-vein injection (60mg/g body wt.) under diethyl ether anaesthesia 48h before use. Diabetes was confirmed by measuring the blood glucose concentration with Dextrostix (Ames Co., Miles Laboratories, Slough, Bucks., U.K.).
Media. Kidney slices were incubated in bicarbonate-buffered saline gassed at 38°C with 02/CO2 (19:1) (Krebs & Henseleit, 1932) . Kidneys were perfused with the same medium but with the addition of bovine plasma albumin (70mg/ml) and equilibrated by overnight dialysis against 20vol. of bicarbonatebuffered saline. Mitochondria were incubated at 30°C in KCl medium (120mM-KCl/20mM-Tris/HCl/ 2mM-EGTA/5mM-potassium phosphate, pH7.6).
Methods
Kidney-cortex slices. Kidneys from male rats (250g) were bisected, the capsule and medulla removed and slices (5-8mg dry wt.) cut with a Stadie-Riggs microtome. The slices were bisected and duplicate paired halves incubated as test and control in 5ml of bicarbonate-buffered saline at 38°C with shaking. At the end of the incubation, slices were removed, drained on filter paper and either dried at 1 10°C for dry-weight determination or processed for enzyme or metabolite assays. Media were acidified with 2% (v/v) HCl04, centrifuged at 0°C for 54000g-min and analysed for metabolites.
Kidney perfusion. This was a modification of the method of Nishiitsutsuji-Uwo et al. (1967) . A peristaltic pump was used instead of a gravity feed to generate the arterial pressure (Weidemann et al., 1969) ; the venous and ureteric cannulae were dispensed with, thus shortening the operation time. The arterial cannula was constructed of stainlesssteel and not of glass. Male rats (350-450g) were starved overnight and anaesthetized with Nembutal (60mg/g of body wt.) intraperitoneally. The operation proceeded as described by Nishiitsutsuji-Uwo etal. (1967) but only ligatures 3, 4 and 5 were required.
After injection of heparin (200 i.u.) into the right ilio-lumbar vein, the arterial cannula was inserted into the mesenteric artery and advanced into the right renal artery and the blood flow replaced immediately by perfusion medium. The kidney was now removed into the perfusion chamber, the medium flowing freely from the open ends of the vena cava. The operation took 5 min to complete and perfusion time was counted from the moment of transfer to the perfusion chamber, when recycling with 100ml of medium began. For monitoring of glucose production, samples (1 ml) were taken from the reservoir and added to 0.1 ml of 20% (v/v) HCI04 and stored at -20°C until assayed. The kidney was freeze-clamped at the end of perfusion at liquid-N2 temperature.
Kidney mitochondria. Mitochondria were prepared from rat kidney cortex by the method of Chappell & Hansford (1972) for preparation of rat liver mitochondria. Mitochondrial protein was measured by the method of Gornall et al. (1949) . The respiratorycontrol ratio (Chappell & Hansford, 1972 ) was 4-6 with 2.5mM-2-oxoglutarate +0.5mM-L-malate.
Pyruvate carboxylation by kidney mitochondria was measured as the incorporation of radioactivity from KH14C03 into acid-stable compounds induced by pyruvate. Mitochondria (0.5mg of protein) were incubated for 5min at 30°C in sealed vessels in 2ml of KCI medium containing KH14C03 (20mM; 0.1 pCi/ ,umol) adjusted to pH7.6 and with other additions given in the text or Tables. Reaction was terminated with 0.2ml of 5M-HCI and the contents were taken to dryness at 100°C. The solid residue was taken up in water (0.2ml) and radioactivity assayed by liquidscintillation spectrometry with toluene/2-methoxyethanol-based scintillator (Severson et al., 1974) . Corrections were applied for incorporation in blank incubations lacking pyruvate. For assay of mitochondrial ATP, incubations were terminated with 2 % (v/v) HC104, and KC104 and precipitated protein were removed by centrifugation at 0°C (54000g-min).
Assay ofmetabolites. For the assay of metabolites, frozen kidney was powdered at liquid-N2 temperature and known weights were extracted with 5% (v/v) HCl04 (2ml/g of powder). After centrifugation the supematant was adjusted to pH7 (glass electrode) with lM-Tris/HCI, pH 7, containing 5M-KOH, and precipitatedTKC1O4 was removed at 0°C by centrifugation.
ATP was assayed in HC104 extracts of mitochondria or kidney slices without neutralization by the luciferin/luciferase assay method of Stanley & Williams (1969) . In neutralized extracts of perfused kidney, or kidney frozen in vivo, ATP, ADP, AMP and pyruvate were assayed spectrophotometrically by the methods of Lamprecht & Trautschold (1963) and Adam (1963) . Glucose, lactate and pyruvate were assayed in HC104 extracts of perfusion or in-1978 cubation media by the spectrophotometric methods of Huggett & Nixon (1952) and Hohorst (1963) . Production of 14C02 from L-[U-14C]lactate was measured in sealed vessels by injection of 2% (v/v) HC104 into the media and collection in Hyamine injected into a centre well. Radioactivity in Hyamine was assayed by liquid-scintillation spectrometry in a toluene-based scintillator (Severson et al., 1974) .
Enzyme assays. Pyruvate dehydrogenase was extracted from frozen kidney powder as described by Whitehouse et al. (1974) and the active form assayed spectrophotometrically by coupling to arylamine acetyltransferase (Coore et al., 1971) . Total pyruvate dehydrogenase (active+inactive forms) was assayed after conversion on incubation with pyruvate dehydrogenase phosphate phosphatase. Conditions were as given by Whitehouse et al. (1974) with addition of 2% (v/v) rat serum (see Wieland, 1975) . Pyruvate carboxylase was assayed by two methods. The spectrophotometric assay involved coupling to malate dehydrogenase and measurement of NADH oxidation. The assay buffer was 0.1 M-Tris/HCI, pH7.4, containing 5mM-MgCl2, 20mM-KHCO3, 0.2mM-NADH, 0.25mM-CoA, 2mM-acetyl phosphate with malate dehydrogenase (3 units/ml) and phosphotransacetylase (2.5 units/ml). The blank rate caused by any contamination with lactate dehydrogenase was read and pyruvate carboxylation was then initiated with ATP (2mM). The radioactive assay used the same assay buffer with KH14C03 (2pCi/ml), 0.25 unit of phosphotransacetylase/ml and 5 units of citrate synthase/ml. Except where otherwise stated, aunit ofenzyme activity is defined as 1 pmol of substrate converted/min. Incubations were for 3 min in sealed bottles and reaction was terminated by injection of 0.2ml of 5M-HCI. After loss of CO2, the contents were taken to dryness at 100°C, reconstituted in 0.2ml of water and radioactivity was assayed with toluene/2-methoxyethanol-based scintillator as described above.
Results and Discussion
Effects of dichloroacetate on glucose production by kidney-cortex slices Table 1 shows rates of glucose production by rat kidney-cortex slices from a number of gluconeogenic substrates. The control rates of glucose production were very similar to those reported by other investigators (e.g., see Krebs et al., 1963) , as were the increases in rates associated with starvation or induction of alloxan-diabetes. In the present experiments glucose production from L-lactate or pyruvate was linear with time for at least 90-120min after an initial burst of glucose output (results not shown). Dichloroacetate (1 mM) consistently inhibited glucose production with L-lactate as substrate by approx, Vol. 170 20-30%. Glucose production from lactate with dichloroacetate remained linear and the inhibition only became statistically significant after 60min (results not shown). In general, dichloroacetate had no significant effect on gluconeogenesis rates with substrates other than lactate, although there was some evidence of inhibition (P<0.05>0.02) with 2-oxoglutarate (starved for 18h) and with succinate or glutamate (alloxan-diabetic).
The concentration of ATP in kidney slices after 30min of incubation averaged 3.9±0.25,umol/g dry wt. (mean+S.E.M. of 20 observations) in normal rats and 3.1±0.04 (four observations) in alloxan-diabetic rats. Dichloroacetate (1 mM) lowered ATP concentration in slices from normal rats by 19% (lactate as substrate) and by 37% (pyruvate as substrate). Identical changes were seen in slices from alloxan-diabetic rats with lactate as substrate. These changes in ATP concentration were statistically significant (P<0.01). It seems unlikely that these changes in ATP concentration were responsible for inhibitory effects of dichloroacetate on glucose production, since the largest fall in ATP concentration was with pyruvate as substrate, but dichloroacetate did not inhibit glucose production from pyruvate (Table 1 ). This conclusion is supported by the results of experiments with perfused kidney (see below).
Effects of dichloroacetate on glucose production by perfused rat kidney As judged by flow rate and ATP concentration, the preparation of perfused kidney used in these experiments was satisfactory (see Bowman, 1970; Ross et al., 1973) . The mean flow rate with the steel cannula used in the present study was 35ml/min at an arterial pressure of 120mmHg as compared with 24ml/min at 130mmHg with a glass cannula [comparable with rates for glass cannula reported by Ross et al. (1973) ]. ATP concentration in perfused kidney was approx. 15% lower than in the kidney in vivo, but this seemed to reflect a general decrease in the concentration of adenine nucleotides as opposed to a decrease in ratios of ATP/ADP or ATP/AMP (see Table 2 ). However, there were no significant changes in the concentrations of ATP, ADP or AMP (Table 2) (Table 3) . Dichloroacetate (1 mM) inhibited glucose production from L-lactate (to 27% of control), but had no effect on glucose production from pyruvate.
1978 Table 3 . Effect ofdichloroacetate on glucose output by perfused rat kidney Rat kidneys were perfused by recycling with lOOml of bicarbonate-buffered saline (Krebs & Henseleit, 1932) containing bovine plasma albumin (70mg/ml) through the renal artery at 37°C. Perfusion was for 60 or 120min and dichloroacetate was introduced at 30 or 60min respectively. For other details of perfusion and methods of analysis, see the Experimental section. Rates of glucose production were calculated from the linear regression of the mean values for the numbers of perfusion experiments stated; the number of points (glucose production against time of perfusion) is given in parentheses. Values for glucose production are given as the slope ± S.E. in linear regression analysis. *Comparing 5-30min periods of perfusion between two groups of diabetic animals, P> 0.05. **Comparing 35-60min periods of perfusion between two groups of diabetic animals, P< 0.001.
[Dichloro Time (min) Fig. 1 . Glucose production by perfused kidneysfrom (a) normal rats starvedfor 18 h and (b) fed alloxan-diabetic rats Kidneys were perfused by recycling 100ml of bicarbonate-buffered saline (Krebs & Henseleit, 1932) gassed with 02/ C02 (19:1) containing bovine plasma albumin (70mg/ml) and L-lactate (10mM). *, Control (four perfusions); A, dichloroacetate to 1 mm at time shown by arrow (four perfusions). The rates of glucose production in Table 3 (lines 1-4 and 9-12 respectively) were calculated from the slopes of the lines shown in (a) and (b) respectively.
Glucose production by perfused kidneys from alloxan-diabetic rats was not linear (Fig. 1, Table 3 ). Effects of dichloroacetate on rates of glucose production were measured in two groups of perfused kidneys without or with 1 mm-dichloroacetate added Vol. 170 after 30min. In the absence of dichloroacetate, rates of glucose production were identical in both groups (5-30min, Table 3 ), but addition of dichloroacetate inhibited glucose production to 13 % of the control value (35-60min; Table 3 ). Mechanism of action of dichloroacetate on lactate gluconeogenesis in rat kidney Dichloroacetate inhibits glucose production from lactate, but not from pyruvate in kidney-cortex slices or in perfused rat kidney. Dichloroacetate is known to effect conversion of inactive (phosphorylated) pyruvate dehydrogenase into active (dephosphorylated) pyruvate dehydrogenase, through inhibition of the pyruvate dehydrogenase kinase reaction, in a number of rat tissues including kidney (Whitehouse et al., 1974; see below). In kidney, lactate metabolism is partitioned between oxidation (pyruvate dehydrogenase) and glucose production (pyruvate carboxylase). Thus, if the flux of extracellular lactate to intramitochondrial pyruvate limits overall lactate utilization in rat kidney, activation ofpyruvate dehydrogenase and hence pyruvate oxidation with dichloroacetate could inhibit glucose production. This might not obtain with pyruvate as substrate. The Km of rat kidney pyruvate dehydrogenase for pyruvate is not known. The Km of bovine kidney and pig heart pyruvate dehydrogenases for pyruvate is 25-50AM. The Km of rat kidney pyruvate carboxylase for pyruvate is 240AM (M. C. Scrutton, personal communication). We have studied the carboxylation of pyruvate in rat kidney mitochondria and the Km for extramitochondrial pyruvate was 79pM, which is entirely consistent with Dr. M. C. Scrutton's estimate, as mitochondria concentrate pyruvate (Halestrap & Denton, 1974) .
The concentration of pyruvate has been measured in kidneys perfused with lOmM-L-lactate for 60min with or without 1 mM-dichloroacetate. With kidneys from normal rats starved for 18 h, dichloroacetate lowered the tissue pyruvate from 0.09±0.02 to 0.02±0.008 (mean±s.E.M., ,mol/ml of tissue water for four observations in each group). With kidneys from fed alloxan-diabetic rats, the values were 0.16 ±0.03 (control, five observations) and 0.04±0.03 (dichloroacetate-treated, four observations). This fall in tissue pyruvate concentration with dichloroacetate could be an important factor in the observed inhibition of gluconeogenesis; we decided to ascertain whether this was due to activation of pyruvate dehydrogenase and pyruvate oxidation.
Dichloroacetate andpyruvate dehydrogenase activity
The total pyruvate dehydrogenase activity (i.e. the sum of active and inactive forms) averaged 6.8 ±0.25 units/g dry wt. in kidney slices (mean±s.E.M. of 40 observations). The slices were incubated for 60min in medium containing 10mM-lactate or l0mm-2-oxoglutarate with or without 1 mM-dichloroacetate. Neither substrate nor dichloroacetate affected total pyruvate dehydrogenase activity. The total activity of pyruvate dehydrogenase in kidneys removed from fed rats under Nembutal anaesthesia is 6.6 ±0.71 units/g dry wt. (five observations; Stansbie et al., 1976) . The total activity of pyruvate dehydrogenase in kidneys from fed rats perfused for 60min with lOmM-L-lactate was 6.6±0.83 units/g dry wt. (four observations). The concentration of active dehydrogenase and the effect of dichloroacetate is shown in Table 4 (total pyruvate dehydrogenase was not a routine assay in these experiments).
In experiments in vivo, the concentration of active dehydrogenase in kidneys from control rats (receiving 0.9 % NaCl by injection) was decreased to about 10-15 % of the fed normal control by starvation or by alloxan-diabetes, as first shown by Wieland et al. (1971) . Injection of dichloroacetate increased the concentration of dehydrogenase in kidneys from fed, starved or alloxan-diabetic rats; the increase was about 10-fold in starved or diabetic animals and about 40% in fed normal animals (Table 4 ). These observations confirm that dichloroacetate effects conversion of pyruvate dehydrogenase into its active form in kidney in vivo (cf. Whitehouse et al., 1974) .
In kidneys from starved rats or alloxan-diabetic rats perfused with lOmM-L-lactate, the concentration of active dehydrogenase was much higher than in the kidney in vivo. This may reflect differences in substrate supply in the two situations. Dichloroacetate (1 mM) increased the concentration ofactive dehydrogenase in kidneys from normal starved rats perfused with 10mm-lactate, but it had no effect with 10mM-pyruvate. The lack of effect with pyruvate was not unexpected because pyruvate is itself an inhibitor of the pyruvate dehydrogenase kinase reactions and may share a common mechanism with dichloroacetate. In kidneys of alloxan-diabetic rats perfused with 10MM-L-lactate for 60min, dichloroacetate did not increase pyruvate dehydrogenase activity (Table  4) .
In kidney-cortex slices of fed rats incubated with lOmM-L-lactate or 10mM-2-oxoglutarate, pyruvate dehydrogenase was mainly in the active form (approx. 80 % total activity) and dichloroacetate had no effect on the concentration of active dehydrogenase after 60min of incubation. In the same experiment dichloroacetate decreased glucose production with L-lactate from 146±8.3 to 117±7.4 (P<0.05 for 16 observations in each group); and dichloroacetate decreased glucose production with 2-oxoglutarate from 165+8.2 to 138±5.3 (P<0.05 for nine observations in each group).
These observations indicate that the inhibitory effect of dichloroacetate on glucose production from lactate can occur without an increase in the concentration of active pyruvate dehydrogenase. Only in the kidneys of normal starved rats perfused with lactate was the activity ofthe dehydrogenase increased by dichloroacetate.
1978 Table 4 . Effect ofdichloroacetate on activity ofpyruvate dehydrogenase (active form) in rat kidney In experiments in vivo, rats were injected intraperitoneally with dichloroacetate (125mg/g body wt.) at 0 and 30min. After 60min, rats were anaesthetized with Nembutal (see the Experimental section) and the right kidney was removed and freeze-clamped at liquid-N2 temperature. Kidneys were perfused under conditions given at the head of Table 3 for 60min and freeze-clamped at liquid-N2 temperature; dichloroacetate was added after 30min. Kidney slices were prepared and incubated (see the Experimental section) for 60min, separated and frozen in liquid N2. Kidneys or kidney-cortex slices were powdered in a mortar at liquid-N2 temperature. A weighed amount of powder was extracted in a Polytron PT 10 homogenizer as described by Whitehouse et al. (1974) and pyruvate dehydrogenase was assayed spectrophotometrically by coupling to arylamine acetyltransferase as described by Coore et al. (1971) . The concentration of dichloroacetate was 1 mm in slice and perfusion experiments. The concentration of dichloroacetate in the circulation in experiments in vivo was 3.6M after 60min. *P<0.01 compared with control. **P<0.001 compared with control. Values are means ± S.E.M. for the numbers of observations given in parentheses.
Pyruvate dehydrogenase (active form) (units/g dry wt.) 
Dichloroacetate andpyruvate carboxylation in kidney mitochondria
The early reactions in glucose production from lactate involve cell uptake of lactate, the lactate dehydrogenase reaction, mitochondrial uptake of pyruvate and the pyruvate carboxylase reaction. Dichloroacetate inhibited lactate uptake in kidney slices, but whether this was a primary action of dichloroacetate on lactate uptake or secondary to diminished lactate conversion into glucose could not be ascertained. The lactate dehydrogenase reaction in a supernatant fraction of rat kidney cortex was not Table 6 . Effect ofdichloroacetate on pyruvate carboxylation in rat kidney-cortex mitochondria Rat kidney mitochondria (0.5mg of protein) were incubated in 2ml of KCI medium (120mM-KCI, 25mM-Tris/HCI, 5mM-potassium phosphate, 2mM-EGTA, pH7.6) containing KH14C03 (20mM; O.1 pCi/pumol) adjusted to pH7.6.
Incubations were for 5 min at 30°C in sealed vessels. The reaction was terminated by addition of 0.2ml of SM-HCI, and the contents were taken to dryness at 100°C. The solid residue was taken up in 0.2ml of water and radioactivity assayed by liquid-scintillation spectrometry with toluene/2-methoxyethanol scintillator (Severson et al., 1974 (Halestrap, 1975) (Wimhurst & Manchester, 1970) . The possibility that dichloroacetate may inhibit pyruvate carboxylase directly was not tested with kidney pyruvate carboxylase, but dichloroacetate (0.5, 1 and 2mM) had no effect on the activity of partially purified liver pyruvate carboxylase over a range of pyruvate concentrations from 50gM to 1 mM.
Discussion
When dichloroacetate is given in vivo to starved or alloxan-diabetic rats or to diabetic patients, it lowers blood concentrations oflactate, pyruvate, alanine and glucose (McAllister et al., 1973; Blackshear et al., 1974 Blackshear et al., , 1975 Whitehouse et al., 1974) . These effects of dichloroacetate have been attributed to conversion of pyruvate dehydrogenase into its active form with concomitant removal of lactate, pyruvate and alanine by oxidation. The fall in blood glucose concentration is assumed to result from this interruption in the normal supply of gluconeogenic precursors. The present study has shown that in the rat kidney glucose production itself is inhibited when the substrate is lactate, with concentrations of dichloroacetate found in the circulation after the administration of effective doses in vivo; this contrasts with the lack of effect in rat hepatocytes (Crabb et al., 1976 ; S. C. Sharples & P. J. Randle, unpublished work Ross, personal communication) but the effect is too small to account for more than 20% of the inhibition of glucose production. The observation that dichloroacetate is an inhibitor of lactate gluconeogenesis in kidney, but not in liver, and that it is more effective in the perfused kidney than in slices, might suggest nevertheless that the functional topography of the kidney (i.e. glomerular filtration andtubular function) isinvolved.
